Godfrey T - Search Results

1

Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.

Tang C, Godfrey T, Stawell R, Nikpour M. Tang C, et al. Among authors: godfrey t. Intern Med J. 2012 Sep;42(9):968-78. doi: 10.1111/j.1445-5994.2012.02886.x. Intern Med J. 2012. PMID: 22827853 Review.

2

Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.

Lee AB, Godfrey T, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, Clemens L, Wilson AM, Nikpour M, Prior DL, Best JD, Jenkins AJ. Lee AB, et al. Among authors: godfrey t. Intern Med J. 2006 Apr;36(4):237-43. doi: 10.1111/j.1445-5994.2006.01044.x. Intern Med J. 2006. PMID: 16640741

3

Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study.

Golder V, Huq M, Franklyn K, Calderone A, Lateef A, Lau CS, Lee ALH, Navarra STV, Godfrey T, Oon S, Hoi AYB, Morand EF, Nikpour M. Golder V, et al. Among authors: godfrey t. Semin Arthritis Rheum. 2017 Jun;46(6):798-803. doi: 10.1016/j.semarthrit.2017.01.007. Epub 2017 Jan 18. Semin Arthritis Rheum. 2017. PMID: 28216192

4

Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors.

Griffin MD, Wilson LM, Mok YF, Januszewski AS, Wilson AM, Karschimkus CS, Romas E, Lee AB, Godfrey T, Wong M, Clemens L, Jenkins AJ, Howlett GJ. Griffin MD, et al. Among authors: godfrey t. Clin Biochem. 2010 Feb;43(3):278-86. doi: 10.1016/j.clinbiochem.2009.10.010. Epub 2009 Oct 24. Clin Biochem. 2010. PMID: 19857478

5

Presence of HIV infection in patients diagnosed with systemic lupus erythematosus.

Clutterbuck DJ, Watson J, De Ruiter A, Godfrey T, Bradbeer C. Clutterbuck DJ, et al. Among authors: godfrey t. Rheumatology (Oxford). 2000 Sep;39(9):1047-8. doi: 10.1093/rheumatology/39.9.1047-a. Rheumatology (Oxford). 2000. PMID: 10986318 No abstract available.

6

Therapeutic advances in systemic lupus erythematosus.

Godfrey T, Khamashta MA, Hughes GR. Godfrey T, et al. Curr Opin Rheumatol. 1998 Sep;10(5):435-41. doi: 10.1097/00002281-199809000-00007. Curr Opin Rheumatol. 1998. PMID: 9746859 Review.

7

Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients.

Godfrey T, Cuadrado MJ, Fofi C, Abbs I, Khamashta MA, Nunan T, Hughes GR. Godfrey T, et al. Rheumatology (Oxford). 2001 Mar;40(3):324-8. doi: 10.1093/rheumatology/40.3.324. Rheumatology (Oxford). 2001. PMID: 11285381

8

Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature.

Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR. Cuadrado MJ, et al. Among authors: godfrey t. Medicine (Baltimore). 2000 Jan;79(1):57-68. doi: 10.1097/00005792-200001000-00006. Medicine (Baltimore). 2000. PMID: 10670410 Review.

9

Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus.

Oon S, Huq M, Godfrey T, Nikpour M. Oon S, et al. Among authors: godfrey t. Semin Arthritis Rheum. 2018 Oct;48(2):221-239. doi: 10.1016/j.semarthrit.2018.01.001. Epub 2018 Jan 6. Semin Arthritis Rheum. 2018. PMID: 29426575

10

Systemic lupus erythematosus: current management.

Godfrey TR, Ryan PF. Godfrey TR, et al. Med J Aust. 2001 Aug 6;175(3):125-6. doi: 10.5694/j.1326-5377.2001.tb143057.x. Med J Aust. 2001. PMID: 11548075 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results